Global Markets
Ipsen (IPN FP) CEO says that they are considering potential US manufacturing investment for plant to make neuroscience drugs
StockNow breaking-news AI analysis
Ipsen considers US neuroscience manufacturing amid broader industry capital investments expanding domestic American pharmaceutical production capabilities.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
